Delivery Order SPE2DB25D3201-SPE2DB25FNTVU

Award Date 6/11/25
Potential Completion Date 7/3/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,960.42, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside contract with a performance period through May 12, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $59,802.10 firm-fixed-price contract is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a $143,525.04 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO, a 1,800mg/30,000 15ml pharmaceutical product, with a completion date of July 1, 2025. The order is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of pharmaceutical products. The contract, valued at $22,081.68, is for the delivery of DARZALEX FASPRO, a specialty medication, and has a completion date of June 7, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and federal healthcare programs. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product, with a ceiling value of $17,940.63 and a period of performance through May 27, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $59,802.10, is for the procurement of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of March 20, 2025. The award was made on February 27, 2025, and there is no set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $23,920.84 and is for the delivery of DARZALEX FASPRO, a pharmaceutical product used for medical treatment. The contract has a firm fixed price pricing type and an ultimate completion date of April 2, 2025. This contract does not have a set-aside designation, indicating it was...
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,204.20 delivery order contract is for the supply of DARZALEX FASPRO, a 1,800mg/30,000 15ml specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of November 14, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $17,940.63 and is a delivery order with a firm fixed price pricing type. The ultimate completion date is April 7, 2025. The contract is for the delivery of DARZALEX FASPRO, a 1,800mg-30,000 15ml pharmaceutical product, to support military treatment facilities, veterans' healthcare...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,960.40, is for the delivery of DARZALEX FASPR 1800 1S medical supplies. The contract has a firm fixed price and is not set aside. Amerisourcebergen Drug Corp is the prime contractor, and the contract has an ultimate completion date of June 13, 2025. The contract is part of...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNTVU
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,960.42, is for the delivery of DARZALEX FASPRO, a specialty pharmaceutical product, to the federal government. The contract is a firm fixed-price, non-set-aside award with a period of performance through July 3, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This delivery order contract is part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for the military and veteran healthcare systems.

Generated 9/10/25, 10:06 AM